NobivacŪ Feline 1-HCPCh (Eclipse 4) is recommended for the vaccination of healthy cats against diseases caused by feline Rhinotracheitis (feline Herpes), Calici, Panleukopenia, and Chlamydia Psittaci. Has been shown to block the replication of canine Parvovirus in cats. This vaccine goes beyond the core antigen protection to help prevent feline Chlamydophila infection. Optimal for healthy outdoor cats or cats that board frequently. Non-adjuvanted formula. Modified live viruses and bacteria. Recommended for use in healthy cats nine weeks of age or older. NobivacŪ Feline 1-HCPCh (Eclipse 4) prevents Feline Rhinotracheitis, Calici, and Panleukopenia Modified live virus Chlamydia Psittaci Modified live bacteria Injectable vaccination For healthy cats nine weeks of age or older Optimal for healthy outdoor cats or cats that board frequently Made in the USA
Nobivac is a registered trademark of Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co. Inc.
Vaccinate healthy cats 9 weeks of age or older.
Transfer contents of the diluent vial to the Nobivac